Angelini Pharma Drug Patent Portfolio
Angelini Pharma owns 1 orange book drug protected by 3 US patents Given below is the list of Angelini Pharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8133893 | Trazodone and trazodone hydrochloride in purified form | 13 Mar, 2029 | Active |
| US7829120 | Trazodone composition for once a day administration | 27 Mar, 2027 | Active |
| US6607748 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture | 29 Jun, 2020 | Expired |
Latest Legal Activities on Angelini Pharma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Angelini Pharma.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 06 Sep, 2023 | US8133893 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 03 May, 2022 | US7829120 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 05 Sep, 2019 | US8133893 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 30 Apr, 2018 | US7829120 |
| Post Issue Communication - Certificate of Correction | 13 Aug, 2012 | US8133893 |
|
Recordation of Patent Grant Mailed
Critical
| 13 Mar, 2012 | US8133893 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 13 Mar, 2012 | US8133893 |
|
Email Notification
Critical
| 23 Feb, 2012 | US8133893 |
|
Issue Notification Mailed
Critical
| 22 Feb, 2012 | US8133893 |
| Dispatch to FDC | 09 Feb, 2012 | US8133893 |
| Printer Rush- No mailing | 01 Feb, 2012 | US8133893 |
|
Pubs Case Remand to TC
Critical
| 31 Jan, 2012 | US8133893 |
|
Application Is Considered Ready for Issue
Critical
| 25 Jan, 2012 | US8133893 |
|
Issue Fee Payment Verified
Critical
| 24 Jan, 2012 | US8133893 |
|
Issue Fee Payment Received
Critical
| 24 Jan, 2012 | US8133893 |
Angelini Pharma's Family Patents
Angelini Pharma Drug List
Given below is the complete list of Angelini Pharma's drugs and the patents protecting them.
1. Oleptro
Oleptro is protected by 3 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8133893 | Trazodone and trazodone hydrochloride in purified form |
13 Mar, 2029
(3 years from now)
| Active |
| US7829120 | Trazodone composition for once a day administration |
27 Mar, 2027
(1 year, 4 months from now)
| Active |
| US6607748 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
29 Jun, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Oleptro's drug page